Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.28 (
chloramphenicol acetyltransferase
)
5,100
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In the human genome, the erythroid-specific hypersensitive site
HS2
enhancer regulates the transcription of the downstream beta-like globin genes 10-50 kilobases away. The mechanism of
HS2
enhancer function is not known. The present study employs RNA protection assays to analyze the transcriptional status of the
HS2
enhancer in transfected recombinant
chloramphenicol acetyltransferase
(
CAT
) plasmids. In erythroid K562 cells in which the
HS2
enhancer is active, the
HS2
sequence directs the synthesis of long enhancer transcripts that are initiated apparently from within the enhancer and elongated through the intervening DNA into the cis-linked
CAT
gene. In nonerythroid HL-60 cells in which the
HS2
enhancer is inactive, long enhancer transcripts are not detectable. Splitting the
HS2
enhancer between two tandem Ap1 sites abolishes the synthesis of a group of long enhancer transcripts and results in loss of enhancer function and transcriptional silencing of the cis-linked
CAT
gene. In directing the synthesis of RNA through the intervening DNA and the gene by a tracking and transcription mechanism, the
HS2
enhancer may (i) open up the chromatin structure of a gene domain and (ii) deliver enhancer binding proteins to the promoter sequence where they may stimulate the transcription of the gene at the cap site.
...
PMID:Transcription of the hypersensitive site HS2 enhancer in erythroid cells. 145 1
To study the regulatory mechanism of pyruvate kinase M gene transcription, we analyzed its chromatin structure and cis-acting DNA regions. Two DNase-I-hypersensitive sites were detected in dRLh-84 hepatoma cells, but not in hepatocytes, which coincides with expression of the M gene in the two types of cells. These sites, designated
HS2
and HS1, were located around the major transcription start site and about 2.9 kb downstream from this site, respectively. A transient
chloramphenicol acetyltransferase
expression assay indicated that the region around HS1 did not show any activity, whereas the upstream region up to -457 had promoter activity in hepatoma cells. Most of this activity was lost by a 5'-deletion from -286 to -225. Further analysis identified a cluster of three cis-acting regions from -279 to -216, which are named boxes A, B and C. These regions did not have any independent effect, but the inclusion of all regions were synergistic. These regions were not active in hepatocytes, suggesting that they have cell-type specificity. A gel mobility shift assay indicated that unidentified, but distinct, nuclear proteins bound to the three boxes. These results suggest that transcriptional regulation of the M gene involves alteration of chromatin structure and binding of proteins to three cis-acting elements.
...
PMID:Transcriptional regulatory regions for expression of the rat pyruvate kinase M gene. 812 88
The locus control region (LCR) regulates transcription of the downstream beta-like globin genes 10 to 50 kb away. Among hypersensitive sites HS4, -3, -2, and -1, which define the LCR in erythroid cells,
HS2
possesses prominent enhancer function. The mechanism by which the
HS2
enhancer and other functional components of the LCR act over the distance is not clear. We have used reverse transcription-PCR and RNase protection assays to analyze the transcriptional statuses of both the endogenous and the transfected
HS2
enhancer in erythroid K562 cells. A novel pattern of
HS2
enhancer transcription was observed. The endogenous
HS2
enhancer was transcribed predominantly in the direction toward the downstream globin genes. The
HS2
enhancer in transfected recombinant
chloramphenicol acetyltransferase
(
CAT
) plasmids was also transcribed predominantly toward the
CAT
gene, regardless of whether the enhancer was placed (i) in the genomic or reverse genomic orientation, (ii) in a position 5' or 3' to the gene, or (iii) at various distances up to 6 kb from the gene. The orientation, position, and distance independence in gene-tropic transcription of the
HS2
enhancer correlates with the observed orientation, position, and distance independence of
HS2
enhancer function and suggests that enhancer transcription may play a role in enhancer function.
...
PMID:Transcription of the HS2 enhancer toward a cis-linked gene is independent of the orientation, position, and distance of the enhancer relative to the gene. 919 30
A 40-bp DNA, consisting of seven tandem GATA repeats, is located near the HS5 site in the 5' boundary area of the locus control region (LCR) of human beta-globin gene. This (GATA)(7) motif, named 5a, exhibits silencer activity in erythroid cells. In transfected, recombinant plasmids containing the
chloramphenicol acetyltransferase
(
CAT
) reporter gene, 5a repressed the activity of the cis-linked housekeeping phosphoglycerate kinase (pgk) promoter; 5a also repressed the activity of the cis-linked
HS2
enhancer regardless of whether the
CAT
gene was driven by the pgk or the epsilon-globin promoter. Repression by 5a was most severe when 5a was spliced upstream of
HS2
at a distance of less than 200 bases from the
HS2
enhancer core. The silencer activity of 5a was independent of whether the component GATA motifs were in head to tail orientation as in the wild type 5a or in head to head or tail to tail orientation as in a mutant 5a. Band shift experiments show that the GATA-1 protein binds to both 5a and the mutant 5a and forms a large protein complex. Together, the results suggest that GATA-1 bound at 5a is a strong, proximal repressor of
HS2
enhancer activity.
...
PMID:A (GATA)(7) motif located in the 5' boundary area of the human beta-globin locus control region exhibits silencer activity in erythroid cells. 1093 58